These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 13104437)

  • 1. Clinical and hematologic effects of triethylene melamine.
    AXELROD AR; BERMAN L; MURPHY RV
    Am J Med; 1953 Nov; 15(5):684-94. PubMed ID: 13104437
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of lymphomatous diseases with triethylene melamine.
    MEYER LM; SCHWARTZ SO; SAWITSKY A; BEYERS MR; RITZ ND; BRAHIN C; DIEFENBACH W; KLEINSCHMIDT W; FRIEDMAN I
    Acta Med Scand Suppl; 1952; 272():1-36. PubMed ID: 13039963
    [No Abstract]   [Full Text] [Related]  

  • 3. [Treatment of hemoblastosis with triethylene melamine].
    LINKE A; LASCH HG
    Dtsch Med Wochenschr; 1953 Jun; 78(25):911-6. PubMed ID: 13068032
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effect of TEM on chronic leukemia, lymphogranulomatosis and lymphosarcoma].
    HAEHNER E; HEINEN W; LOOSEN H; SCHMIDT H
    Med Klin; 1954 May; 49(21):853-4; passim. PubMed ID: 13164965
    [No Abstract]   [Full Text] [Related]  

  • 5. Triethylene melamine (TEM) in the treatment of malignant lymphoid disease.
    HAMBLY CK; ROBERTSON TI
    Med J Aust; 1955 Jun; 42(1 25):900-11. PubMed ID: 13243982
    [No Abstract]   [Full Text] [Related]  

  • 6. [Immediate results of triethylene melamine therapy of neoplastic diseases].
    LENTI G; GAVOSTO F
    Minerva Med; 1953 Jan; 44(1-2):1-19. PubMed ID: 13054386
    [No Abstract]   [Full Text] [Related]  

  • 7. [Early resistance to triethylene melamine].
    LATTANZI A; PARDELLI G
    Riforma Med; 1954 Jan; 68(1):7-12. PubMed ID: 13156339
    [No Abstract]   [Full Text] [Related]  

  • 8. [Our experience with the application of triethylene melamine (TEM) in patients with malignant hemopathies].
    RUVIDIC R; NIKOLIC J
    Med Glas; 1960 Sep; 14():435-42. PubMed ID: 13744964
    [No Abstract]   [Full Text] [Related]  

  • 9. TRIETHYLENE-MELAMINE.
    Br Med J; 1955 Jun; 1(4926):1380-1. PubMed ID: 14363905
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinical trials with triethylene melamine].
    FERRARI M; KASDORF H
    Arch Urug Med Cir Espec; 1953; 42(3-4):134-44. PubMed ID: 14350952
    [No Abstract]   [Full Text] [Related]  

  • 11. Treatment of Hodgkin's disease and the lymphosarcomas.
    MEYER OO
    J Am Med Assoc; 1954 Jan; 154(2):114-20. PubMed ID: 13108678
    [No Abstract]   [Full Text] [Related]  

  • 12. Treatment of leukemia and lymphomata with triethylene melamine.
    WALSH JR; PRATT PT; GRAHAM WE; ZIMMERMAN HJ
    Acta Haematol; 1954 Jun; 11(6):329-38. PubMed ID: 13170978
    [No Abstract]   [Full Text] [Related]  

  • 13. [Comparative studies on the effects of triethylene melamine and x-rays on giant follicular lymphoblastoma (Brill-Symmers' disease)].
    KRUCKEMEYER K; RIEGEL R
    Dtsch Med J; 1955 Aug; 6(15-16):527-31. PubMed ID: 13261794
    [No Abstract]   [Full Text] [Related]  

  • 14. Triethylene melamine in the management of lymphosarcoma.
    SAMPEY JR
    Va Med Mon (1918); 1960 Aug; 87():448-50. PubMed ID: 13856320
    [No Abstract]   [Full Text] [Related]  

  • 15. Triethylene melamine in the treatment of lymphomas and leukemias.
    KARNOFSKY DA
    Med Clin North Am; 1954 Mar; 11():541-54. PubMed ID: 13153527
    [No Abstract]   [Full Text] [Related]  

  • 16. Triethylene melamine in the treatment of lymphomas and other neoplastic diseases.
    BURTNER OW; JENSEN LC; RUMBALL JM
    Ann Intern Med; 1953 Jun; 38(6):1222-44. PubMed ID: 13065973
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical indications for the use of nitrogen mustard and triethylene melamine in malignant lymphomas and leukemias.
    DIAMOND HD
    Ann N Y Acad Sci; 1958 Apr; 68(3):974-8. PubMed ID: 13627744
    [No Abstract]   [Full Text] [Related]  

  • 18. Lymphosarcoma of the tonsil.
    GIARDINO JP; BELL DF
    Clin Proc Child Hosp Dist Columbia; 1953 May; 9(5):98-103. PubMed ID: 13059922
    [No Abstract]   [Full Text] [Related]  

  • 19. Results in the use of triethylene melamine (TEM) in malignant lymphomas and chronic leukemias.
    MEZA ARRAU C; NIJAMKIN A
    Rev Med Chil; 1955 Feb; 83(2):90-5. PubMed ID: 14385308
    [No Abstract]   [Full Text] [Related]  

  • 20. [Cytostasis due to triethylene melamine (TEM) in lymphogranulomatosis and chronic leukemia].
    NEUMANN C
    Klin Wochenschr; 1952 Dec; 30(47-48):1105-8. PubMed ID: 13023980
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.